J.W. Cole Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956K | Buy |
2,457
+656
| +36% | +$255K | 0.02% | 685 |
|
|
2025
Q1 | $783K | Buy |
1,801
+418
| +30% | +$182K | 0.02% | 616 |
|
|
2024
Q4 | $510K | Buy |
1,383
+58
| +4% | +$21.4K | 0.02% | 595 |
|
|
2024
Q3 | $689K | Buy |
1,325
+49
| +4% | +$25.5K | 0.03% | 489 |
|
|
2024
Q2 | $692K | Buy |
1,276
+139
| +12% | +$75.3K | 0.03% | 431 |
|
|
2024
Q1 | $589K | Buy |
1,137
+143
| +14% | +$74.1K | 0.03% | 488 |
|
|
2023
Q4 | $469K | Buy |
994
+109
| +12% | +$51.4K | 0.03% | 507 |
|
|
2023
Q3 | $385K | Sell |
885
-108
| -11% | -$47K | 0.03% | 488 |
|
|
2023
Q2 | $441K | Sell |
993
-69
| -6% | -$30.7K | 0.03% | 458 |
|
|
2023
Q1 | $488K | Buy |
1,062
+6
| +0.6% | +$2.76K | 0.03% | 454 |
|
|
2022
Q4 | $542K | Sell |
1,056
-2
| -0.2% | -$1.03K | 0.04% | 401 |
|
|
2022
Q3 | $481K | Sell |
1,058
-4
| -0.4% | -$1.82K | 0.04% | 408 |
|
|
2022
Q2 | $512K | Hold |
1,062
| – | – | 0.04% | 404 |
|
|
2022
Q1 | $522K | Sell |
1,062
-3
| -0.3% | -$1.48K | 0.04% | 440 |
|
|
2021
Q4 | $494K | Buy |
1,065
+4
| +0.4% | +$1.86K | 0.03% | 468 |
|
|
2021
Q3 | $396K | Sell |
1,061
-2
| -0.2% | -$746 | 0.03% | 295 |
|
|
2021
Q2 | $406K | Sell |
1,063
-60
| -5% | -$22.9K | 0.03% | 493 |
|
|
2021
Q1 | $403K | Buy |
1,123
+198
| +21% | +$71.1K | 0.04% | 434 |
|
|
2020
Q4 | $297K | Buy |
+925
| New | +$297K | 0.03% | 480 |
|
|
2020
Q1 | – | Sell |
-1,244
| Closed | -$376K | – | 206 |
|
|
2019
Q4 | $376K | Buy |
+1,244
| New | +$376K | 0.05% | 364 |
|